Unlike other sectors that invested heavily in workflow SaaS, healthcare's lack of investment means it has less technical debt. This allows a direct jump to AI-native systems, avoiding a costly "rip and replace" cycle and overcoming sunk-cost bias that plagues other industries.
Julie Yoo's startup was founded on the discovery that despite patients waiting weeks for appointments, physician schedules were underutilized. This paradox of high demand and low utilization highlights a massive inefficiency in patient routing and capacity management, creating a significant market opportunity.
The shift to high-deductible plans forced consumers to directly feel the financial burden of healthcare. This created a new willingness to pay out-of-pocket for disruptively priced, superior consumer health services, effectively establishing a viable direct-to-consumer (DTC) market that investors previously dismissed.
While LLMs can provide medical intelligence, they cannot perform physical tasks like drawing blood. The winning model uses AI for a disruptive cost structure internally while delivering a service with a real-world, regulated, or hardware-based moat that cannot be commoditized by a general AI.
Current medical AI relies on electronic health records, which capture only infrequent snapshots of a person's health. The next breakthrough will come from companies that create new, continuous data rails by engaging with patients longitudinally, generating proprietary "N-of-one" datasets for superior models.
Unlike industries that digitized organically, healthcare's transition from paper was kickstarted by a massive federal program paying doctors to implement Electronic Health Records (EHRs). This forced, top-down digitization created the essential system-of-record infrastructure that modern health tech companies now build upon.